Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A South African study found that more than half of adults with advanced HIV had cytomegalovirus (CMV) in their blood — and it quadrupled their odds of dying within 6 months. The findings, published in Open Forum Infectious Diseases, highlight CMV viremia as a critical but often overlooked prognostic marker in outpatients with severely compromised immune systems.
A new study out of South Africa is shining a spotlight on cytomegalovirus (CMV) as a deadly — and underappreciated — complication in people living with advanced HIV. Researchers analyzed 146 adults with CD4 counts below 100 cells/mm³ and found that CMV viremia was strikingly common and strongly tied to early death.
What's particularly notable: most participants were outpatients, not hospitalized patients — suggesting CMV's deadly impact may be even more pronounced in community settings than previously recognized.
CMV viremia is detectable — making it a meaningful target for intervention in a population already facing steep odds. These findings push clinicians to consider routine CMV screening in outpatients with advanced HIV disease, where early identification could translate directly into lives saved.
